Knockout of proteins that promote an M2/IL-4-like activation phenotype has been reported to protect against bleomycin-induced fibrosis and reduce expression of markers associated with IL-4-induced activation of macrophages in the lung (17, 18, 19, 20, 21). Here, IL4 is linked to fibrosis.